GC021109
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GC021109, covering 2015-02-18 to 2016-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease [Phase 1]